NASDAQ:KA Kineta - KA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Kineta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.01 -0.20 (-6.23%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.94▼$3.4150-Day Range$3.01▼$8.3352-Week Range$2.94▼$17.43Volume67,825 shsAverage Volume22,597 shsMarket Capitalization$4.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media About Kineta (NASDAQ:KA) StockKineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.Read More Receive KA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter. Email Address KA Stock News HeadlinesMarch 8, 2023 | finance.yahoo.comKineta to Present at the Oppenheimer 33rd Annual Healthcare ConferenceMarch 6, 2023 | finance.yahoo.comKineta to Host Key Opinion Leader Event on KVA12123: VISTA as an Immuno-Oncology TargetMarch 20, 2023 | Investing Daily (Ad)How This Trader Banked A 97% Win RateDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. March 4, 2023 | ca.finance.yahoo.comKineta, Inc. (KA)March 1, 2023 | finance.yahoo.comKineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory BoardSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive KA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter. Email Address KA Company Calendar Today3/20/2023Next Earnings (Estimated)3/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:KA CUSIPN/A CIK1445283 Webwww.kinetabio.com Phone(206) 378-0400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($20.9937) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,500,000.00 Net Margins-660.61% Pretax Margin-660.61% Return on Equity-263.34% Return on Assets-107.08% Debt Debt-to-Equity RatioN/A Current Ratio2.21 Quick Ratio2.21 Sales & Book Value Annual Sales$8.04 million Price / Sales0.58 Cash FlowN/A Price / Cash FlowN/A Book Value$15.95 per share Price / Book0.19Miscellaneous Outstanding Shares1,550,000Free Float1,360,000Market Cap$4.67 million OptionableNot Optionable Beta0.49 Key ExecutivesShawn P. IadonatoChief Executive Officer & DirectorCraig W. PhilipsPresidentKeith BakerChief Financial OfficerThierry GuillaudeuxChief Scientific OfficerJacques BouchyEVP-Investor Relations & Business DevelopmentKey CompetitorsBright Minds BiosciencesNASDAQ:DRUGAytu BioPharmaNASDAQ:AYTUProcessa PharmaceuticalsNASDAQ:PCSAAridis PharmaceuticalsNASDAQ:ARDSOncorusNASDAQ:ONCRView All CompetitorsInstitutional OwnershipArtal Group S.A.Bought 31,055 shares on 2/13/2023Ownership: 2.004%Renaissance Technologies LLCBought 17,516 shares on 2/13/2023Ownership: 1.128%View All Institutional Transactions KA Stock - Frequently Asked Questions How have KA shares performed in 2023? Kineta's stock was trading at $6.35 at the beginning of 2023. Since then, KA stock has decreased by 52.6% and is now trading at $3.01. View the best growth stocks for 2023 here. When is Kineta's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023. View our KA earnings forecast. What is Kineta's stock symbol? Kineta trades on the NASDAQ under the ticker symbol "KA." Who are Kineta's major shareholders? Kineta's stock is owned by many different institutional and retail investors. Top institutional investors include Artal Group S.A. (2.00%) and Renaissance Technologies LLC (1.13%). How do I buy shares of Kineta? Shares of KA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Kineta's stock price today? One share of KA stock can currently be purchased for approximately $3.01. How much money does Kineta make? Kineta (NASDAQ:KA) has a market capitalization of $4.67 million and generates $8.04 million in revenue each year. The company earns $-39,500,000.00 in net income (profit) each year or ($20.9937) on an earnings per share basis. How can I contact Kineta? Kineta's mailing address is 40 GUEST STREET SUITE 4410, BOSTON MA, 02135. The official website for the company is www.kinetabio.com. The company can be reached via phone at (206) 378-0400 or via email at lroth@burnsmc.com. This page (NASDAQ:KA) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.